These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 20429826)

  • 41. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals.
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    Pharm Res; 2010 Dec; 27(12):2704-14. PubMed ID: 20859662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The contribution of Raman spectroscopy to the analysis of phase transformations in pharmaceutical compounds.
    Hédoux A; Guinet Y; Descamps M
    Int J Pharm; 2011 Sep; 417(1-2):17-31. PubMed ID: 21256937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High throughput solubility measurement with automated polarized light microscopy analysis.
    Sugano K; Kato T; Suzuki K; Keiko K; Sujaku T; Mano T
    J Pharm Sci; 2006 Oct; 95(10):2115-22. PubMed ID: 16871512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amorphous drug delivery systems: molecular aspects, design, and performance.
    Kaushal AM; Gupta P; Bansal AK
    Crit Rev Ther Drug Carrier Syst; 2004; 21(3):133-93. PubMed ID: 15248808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-Throughput Raman Spectroscopy Screening of Excipients for the Stabilization of Amorphous Drugs.
    Chen X; Stoneburner K; Ladika M; Kuo TC; Kalantar TH
    Appl Spectrosc; 2015 Nov; 69(11):1271-80. PubMed ID: 26647050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.
    Indulkar AS; Gao Y; Raina SA; Zhang GG; Taylor LS
    Mol Pharm; 2016 Jun; 13(6):2059-69. PubMed ID: 27138900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting aqueous solubility: the role of crystallinity.
    Chu KA; Yalkowsky SH
    Curr Drug Metab; 2009 Dec; 10(10):1184-91. PubMed ID: 20166998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?
    Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
    Int J Pharm; 2018 Mar; 538(1-2):243-249. PubMed ID: 29341914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
    Yang Z; Nollenberger K; Albers J; Qi S
    Mol Pharm; 2014 Jul; 11(7):2453-65. PubMed ID: 24897345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The discovery and investigation of a crystalline solid solution of an active pharmaceutical ingredient.
    Patel MA; AbouGhaly MHH; Chadwick K
    Int J Pharm; 2017 Oct; 532(1):166-176. PubMed ID: 28847668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
    Heinz A; Strachan CJ; Gordon KC; Rades T
    J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
    Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
    Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An investigation into the influence of counterion on the properties of some amorphous organic salts.
    Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
    Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel tactics for designing water-soluble molecules in drug discovery.
    Walker MA
    Expert Opin Drug Discov; 2014 Dec; 9(12):1421-33. PubMed ID: 25226793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance.
    Hancock BC; Carlson GT; Ladipo DD; Langdon BA; Mullarney MP
    Int J Pharm; 2002 Jul; 241(1):73-85. PubMed ID: 12086723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Polymorph transformation of solid drugs].
    Zhang Q; Mei XF
    Yao Xue Xue Bao; 2015 May; 50(5):521-7. PubMed ID: 26234130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs.
    Raina SA; Zhang GGZ; Alonzo DE; Wu J; Zhu D; Catron ND; Gao Y; Taylor LS
    J Pharm Sci; 2014 Sep; 103(9):2736-2748. PubMed ID: 24382592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formation, Physicochemical Characterization, and Thermodynamic Stability of the Amorphous State of Drugs and Excipients.
    Martino PD; Magnoni F; Peregrina DV; Gigliobianco MR; Censi R; Malaj L
    Curr Pharm Des; 2016; 22(32):4959-4974. PubMed ID: 27464724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
    Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
    Li B; Konecke S; Wegiel LA; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Oct; 98(1):1108-16. PubMed ID: 23987452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.